GRANULOCYTE COLONY STIMULATING FACTOR

GRANULOCYTE COLONY STIMULATING FACTOR was reported 2180 times

GRANULOCYTE COLONY STIMULATING FACTOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRE-ENGRAFTMENT IMMUNE REACTION 14 0.1750
1 ENTERITIS LEUKOPENIC 1 0.1429
2 HEPATIC CANDIDIASIS 8 0.1176
3 MYELOBLAST PERCENTAGE INCREASED 2 0.0952
4 HAEMATOPOIETIC STEM CELL MOBILISATION 5 0.0781
5 GASTRIC LAVAGE ABNORMAL 1 0.0667
6 XANTHOCHROMIA 2 0.0556
7 FLAGELLATE DERMATITIS 3 0.0462
8 RHABDOID TUMOUR 2 0.0385
9 ENDOTOXAEMIA 1 0.0385
10 ENGRAFTMENT SYNDROME 22 0.0372
11 SARCOMA METASTATIC 5 0.0360
12 MENINGITIS TUBERCULOUS 20 0.0358
13 CYSTITIS KLEBSIELLA 6 0.0357
14 CAROTIDYNIA 2 0.0345
15 ACUTE GRAFT VERSUS HOST DISEASE ORAL 1 0.0323
16 OSTEOSARCOMA METASTATIC 3 0.0316
17 CONUS MEDULLARIS SYNDROME 2 0.0308
18 PERIUMBILICAL ABSCESS 2 0.0299
19 ECCRINE SQUAMOUS SYRINGOMETAPLASIA 1 0.0278
20 HEPATOSPLENIC CANDIDIASIS 4 0.0272
21 BLOOD STEM CELL HARVEST 1 0.0270
22 PARASPINAL ABSCESS 4 0.0258
23 HUMAN HERPESVIRUS 6 INFECTION 48 0.0254
24 ACUTE GRAFT VERSUS HOST DISEASE 113 0.0247
25 GRANULICATELLA INFECTION 1 0.0238
26 CORYNEBACTERIUM BACTERAEMIA 2 0.0235
27 SCHISTOCYTOSIS 2 0.0230
28 AEROMONA INFECTION 1 0.0217
29 FUSARIUM INFECTION 15 0.0214
30 ISCHAEMIC ENTERITIS 2 0.0206
31 MENINGOENCEPHALITIS HERPETIC 9 0.0201
32 SUBCLAVIAN ARTERY OCCLUSION 2 0.0198
33 CAPILLARY NAIL REFILL TEST ABNORMAL 2 0.0192
34 REFRACTORINESS TO PLATELET TRANSFUSION 2 0.0183
35 NEUTROPENIC INFECTION 17 0.0178
36 GENITAL INFECTION MALE 1 0.0175
37 ENGRAFT FAILURE 5 0.0174
38 ADENOVIRAL HEPATITIS 4 0.0170
39 IDIOPATHIC PNEUMONIA SYNDROME 5 0.0168
40 STENOTROPHOMONAS SEPSIS 2 0.0165
41 CEREBRAL CIRCULATORY FAILURE 1 0.0161
42 HERPES SIMPLEX VIRAEMIA 2 0.0160
43 GLOMERULONEPHRITIS FOCAL 1 0.0159
44 ANGIOLIPOMA 1 0.0156
45 GEOTRICHUM INFECTION 3 0.0142
46 MESENTERIC ARTERIAL OCCLUSION 2 0.0142
47 BACTERIAL CULTURE POSITIVE 1 0.0141
48 MYELOID LEUKAEMIA 7 0.0140
49 GINGIVITIS ULCERATIVE 3 0.0140
50 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0139
51 AMNIORRHEXIS 1 0.0139
52 GASTROINTESTINAL MUCOSAL DISORDER 9 0.0137
53 MEDULLOBLASTOMA 2 0.0134
54 CAECITIS 6 0.0133
55 ENCEPHALITIS VIRAL 16 0.0131
56 LOWER RESPIRATORY TRACT INFECTION FUNGAL 5 0.0129
57 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 18 0.0127
58 GRAFT VERSUS HOST DISEASE IN SKIN 28 0.0127
59 ACQUIRED TRACHEO-OESOPHAGEAL FISTULA 1 0.0127
60 COMBINED IMMUNODEFICIENCY 2 0.0124
61 ANTI-ERYTHROCYTE ANTIBODY POSITIVE 1 0.0122
62 BONE MARROW LEUKAEMIC CELL INFILTRATION 1 0.0122
63 CHRONIC GRAFT VERSUS HOST DISEASE 44 0.0122
64 CHORIORETINAL SCAR 1 0.0120
65 CITROBACTER INFECTION 5 0.0117
66 ANTI-PLATELET ANTIBODY POSITIVE 2 0.0116
67 BASOPHIL PERCENTAGE INCREASED 2 0.0114
68 ANTITHROMBIN III DEFICIENCY 1 0.0112
69 CHIMERISM 1 0.0112
70 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 2 0.0107
71 MONOCYTE COUNT DECREASED 13 0.0106
72 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 1 0.0106
73 CENTRAL NERVOUS SYSTEM MASS 1 0.0105
74 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 2 0.0099
75 CYSTITIS HAEMORRHAGIC 39 0.0097
76 CLONAL EVOLUTION 1 0.0096
77 ADENOVIRAL HAEMORRHAGIC CYSTITIS 2 0.0096
78 BRONCHOALVEOLAR LAVAGE ABNORMAL 2 0.0096
79 ACUTE MYELOID LEUKAEMIA RECURRENT 20 0.0093
80 TERATOMA 2 0.0093
81 CYTOMEGALOVIRUS GASTROENTERITIS 2 0.0093
82 B-CELL LYMPHOMA RECURRENT 5 0.0092
83 BONE MARROW TRANSPLANT REJECTION 2 0.0091
84 GASTROENTERITIS BACTERIAL 3 0.0091
85 ADENOVIRUS INFECTION 26 0.0090
86 DECEREBRATION 1 0.0088
87 BONE MARROW NECROSIS 2 0.0085
88 ZYGOMYCOSIS 4 0.0085
89 FUSOBACTERIUM INFECTION 1 0.0085
90 BONE MARROW TUMOUR CELL INFILTRATION 1 0.0085
91 CYTOMEGALOVIRUS ENTERITIS 3 0.0084
92 ACHROMOBACTER INFECTION 1 0.0083
93 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 23 0.0083
94 MYELOPROLIFERATIVE DISORDER 2 0.0083
95 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0082
96 ANGIOSARCOMA METASTATIC 1 0.0082
97 VITAMIN B1 DECREASED 2 0.0080
98 CYTOMEGALOVIRUS GASTRITIS 2 0.0079
99 HERPES SIMPLEX REACTIVATION 3 0.0079
100 BONE MARROW INFILTRATION 3 0.0078
101 GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0077
102 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0076
103 HAEMOSIDEROSIS 2 0.0075
104 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 1 0.0074
105 STREPTOCOCCAL BACTERAEMIA 8 0.0074
106 RENAL ARTERY OCCLUSION 2 0.0073
107 CHLOROMA 3 0.0071
108 BUCCAL MUCOSAL ROUGHENING 1 0.0070
109 AUTOIMMUNE THROMBOCYTOPENIA 3 0.0069
110 HAEMATOMA INFECTION 4 0.0069
111 LEISHMANIASIS 2 0.0069
112 VENOOCCLUSIVE DISEASE 17 0.0068
113 GASTRITIS ATROPHIC 1 0.0066
114 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 2 0.0064
115 HEPATIC VEIN THROMBOSIS 2 0.0063
116 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
117 COLITIS EROSIVE 1 0.0063
118 5Q MINUS SYNDROME 1 0.0063
119 KLEBSIELLA SEPSIS 7 0.0062
120 IIIRD NERVE PARALYSIS 5 0.0062
121 APLASIA 12 0.0061
122 DIFFUSE ALVEOLAR DAMAGE 7 0.0061
123 VENOOCCLUSIVE LIVER DISEASE 30 0.0061
124 CYTOMEGALOVIRUS VIRAEMIA 27 0.0061
125 ANAPLASTIC ASTROCYTOMA 1 0.0061
126 CYTOMEGALOVIRUS INFECTION REACTIVATION 26 0.0059
127 GAS GANGRENE 2 0.0058
128 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
129 CATHETER SITE ABSCESS 1 0.0057
130 GASTROENTERITIS CLOSTRIDIAL 2 0.0057
131 RESPIRATORY TRACT INFECTION FUNGAL 3 0.0057
132 ENTEROCOCCAL BACTERAEMIA 6 0.0057
133 FAT EMBOLISM 2 0.0056
134 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 12 0.0056
135 CYTOMEGALOVIRUS TEST POSITIVE 10 0.0056
136 GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0056
137 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
138 CYTOMEGALOVIRUS ANTIGEN POSITIVE 1 0.0055
139 MUCOSAL INFLAMMATION 139 0.0053
140 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 2 0.0053
141 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0053
142 HYDROURETER 2 0.0053
143 CYTOMEGALOVIRUS INFECTION 87 0.0052
144 CYSTITIS VIRAL 2 0.0052
145 METAPNEUMOVIRUS INFECTION 4 0.0051
146 EXTRADURAL ABSCESS 4 0.0051
147 BONE MARROW TOXICITY 6 0.0051
148 FEBRILE NEUTROPENIA 333 0.0050
149 BREAST CALCIFICATIONS 4 0.0050
150 LYMPHOCYTE PERCENTAGE INCREASED 2 0.0049
151 ADRENAL MASS 4 0.0048
152 VARICELLA ZOSTER VIRUS INFECTION 10 0.0048
153 CORONA VIRUS INFECTION 2 0.0047
154 AUTOIMMUNE COLITIS 3 0.0047
155 HILAR LYMPHADENOPATHY 4 0.0045
156 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 8 0.0045
157 ACID BASE BALANCE ABNORMAL 1 0.0045
158 FEEDING INTOLERANCE 2 0.0044
159 REFUSAL OF TREATMENT BY RELATIVE 2 0.0044
160 CONTINUOUS POSITIVE AIRWAY PRESSURE 1 0.0043
161 ENDOTHELIAL DYSFUNCTION 1 0.0043
162 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 11 0.0043
163 PELVIC FLUID COLLECTION 3 0.0043
164 MINIMAL RESIDUAL DISEASE 2 0.0041
165 LEUKAEMIA RECURRENT 7 0.0041
166 CLOSTRIDIAL SEPSIS 1 0.0041
167 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 34 0.0041
168 PNEUMONIA CYTOMEGALOVIRAL 8 0.0041
169 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 1 0.0041
170 THERAPY RESPONDER 2 0.0041
171 ENTEROBACTER TEST POSITIVE 1 0.0041
172 GRAFT VERSUS HOST DISEASE 29 0.0040
173 CHROMOSOME ANALYSIS ABNORMAL 1 0.0039
174 ACUTE LYMPHOCYTIC LEUKAEMIA 11 0.0039
175 CAPILLARY LEAK SYNDROME 8 0.0039
176 BRONCHOPULMONARY ASPERGILLOSIS 30 0.0039
177 JC VIRUS INFECTION 6 0.0037
178 FOETAL ARRHYTHMIA 1 0.0037
179 ENTEROCOCCAL SEPSIS 3 0.0037
180 HAEMATOTOXICITY 35 0.0037
181 TRANSPLANT FAILURE 9 0.0037
182 ENCEPHALOMYELITIS 1 0.0037
183 PNEUMOCYSTIS JIROVECI PNEUMONIA 8 0.0036
184 PERIPHERAL MOTOR NEUROPATHY 5 0.0036
185 SARCOMA 4 0.0035
186 FEBRILE BONE MARROW APLASIA 15 0.0035
187 ELECTRIC SHOCK 3 0.0035
188 XEROPHTHALMIA 2 0.0034
189 BACTERIAL SEPSIS 11 0.0034
190 CAMPYLOBACTER GASTROENTERITIS 2 0.0034
191 SECOND PRIMARY MALIGNANCY 28 0.0034
192 CANDIDA SEPSIS 3 0.0033
193 PLASMA CELL LEUKAEMIA 2 0.0033
194 URINARY TRACT INFECTION PSEUDOMONAL 2 0.0033
195 FUNGAL ENDOCARDITIS 1 0.0033
196 ERYTHROPENIA 1 0.0033
197 BLADDER TAMPONADE 1 0.0033
198 PNEUMONIA FUNGAL 13 0.0033
199 ENTEROCOLITIS VIRAL 1 0.0033
200 ASPERGILLUS TEST POSITIVE 1 0.0032
201 HERPES SIMPLEX 21 0.0032
202 STEM CELL TRANSPLANT 8 0.0032
203 BONE MARROW FAILURE 65 0.0032
204 HEPATIC NECROSIS 12 0.0032
205 BACILLUS INFECTION 2 0.0032
206 GLOMERULOSCLEROSIS 2 0.0032
207 BACTERIAL TRANSLOCATION 1 0.0032
208 ASPERGILLOMA 1 0.0031
209 HAEMATOLOGY TEST ABNORMAL 1 0.0031
210 SPUTUM PURULENT 2 0.0030
211 MYELOPROLIFERATIVE NEOPLASM 2 0.0030
212 HYPOGONADISM 3 0.0030
213 CYTOKINE STORM 2 0.0029
214 COMPUTERISED TOMOGRAM THORAX ABNORMAL 2 0.0029
215 CENTRAL NERVOUS SYSTEM LYMPHOMA 4 0.0029
216 HEART TRANSPLANT REJECTION 3 0.0029
217 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
218 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0029
219 PSEUDOMONAL SEPSIS 5 0.0029
220 H1N1 INFLUENZA 4 0.0028
221 SCEDOSPORIUM INFECTION 2 0.0028
222 DELAYED GRAFT FUNCTION 2 0.0028
223 VOCAL CORD PARALYSIS 5 0.0028
224 TOXOPLASMOSIS 3 0.0028
225 GLOMERULONEPHRITIS PROLIFERATIVE 1 0.0028
226 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 6 0.0027
227 CEREBRAL VASOCONSTRICTION 2 0.0027
228 MUCORMYCOSIS 7 0.0027
229 ENTEROCOCCAL INFECTION 13 0.0027
230 FOLATE DEFICIENCY 3 0.0026
231 PULMONARY MYCOSIS 2 0.0026
232 GASTROINTESTINAL ANASTOMOTIC LEAK 1 0.0026
233 PERIPHERAL SENSORY NEUROPATHY 15 0.0026
234 CYTOMEGALOVIRUS CHORIORETINITIS 5 0.0026
235 ENDOCARDITIS BACTERIAL 2 0.0025
236 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE 1 0.0025
237 PNEUMONIA STAPHYLOCOCCAL 5 0.0025
238 EYE INFECTION TOXOPLASMAL 1 0.0025
239 NEUTROPENIC SEPSIS 18 0.0025
240 VITAMIN B12 INCREASED 2 0.0025
241 PHARYNGEAL INFLAMMATION 3 0.0025
242 OTITIS EXTERNA 3 0.0025
243 FUNGAL SEPSIS 2 0.0024
244 SYSTEMIC CANDIDA 6 0.0024
245 BLOOD PRODUCT TRANSFUSION DEPENDENT 1 0.0024
246 BK VIRUS INFECTION 8 0.0024
247 PSEUDOMONAL BACTERAEMIA 2 0.0023
248 PLATELET TRANSFUSION 3 0.0023
249 VASCULAR PSEUDOANEURYSM 4 0.0023
250 TRANSFUSION REACTION 2 0.0023
251 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 3 0.0023
252 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
253 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 1 0.0022
254 GASTROINTESTINAL INFECTION 20 0.0022
255 ENTEROCOLITIS INFECTIOUS 2 0.0022
256 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
257 OTOTOXICITY 4 0.0022
258 BILIARY SEPSIS 1 0.0022
259 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
260 INTESTINAL FISTULA 3 0.0021
261 ACUTE MYELOID LEUKAEMIA 33 0.0021
262 BRAIN STEM HAEMORRHAGE 2 0.0021
263 APLASTIC ANAEMIA 11 0.0021
264 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
265 LYMPHADENOPATHY MEDIASTINAL 4 0.0021
266 BLAST CELLS PRESENT 1 0.0021
267 CEREBRAL ARTERY STENOSIS 1 0.0020
268 SUBCUTANEOUS EMPHYSEMA 2 0.0020
269 CARDIOTOXICITY 18 0.0020
270 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1 0.0020
271 GINGIVAL HYPERTROPHY 3 0.0020
272 BACTERAEMIA 23 0.0019
273 MYELODYSPLASTIC SYNDROME 28 0.0019
274 FAECAL VOLUME INCREASED 1 0.0019
275 IRON OVERLOAD 2 0.0019
276 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
277 TUMOUR LYSIS SYNDROME 16 0.0018
278 BLOOD PH INCREASED 1 0.0018
279 EPSTEIN-BARR VIRAEMIA 2 0.0018
280 EPSTEIN-BARR VIRUS INFECTION 11 0.0018
281 NEUTROPHIL COUNT INCREASED 18 0.0018
282 RADIATION SKIN INJURY 2 0.0017
283 PAROTITIS 2 0.0017
284 EJECTION FRACTION 1 0.0017
285 CELLULITIS ORBITAL 1 0.0017
286 RECURRENT CANCER 7 0.0017
287 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 4 0.0017
288 FEBRILE INFECTION 2 0.0017
289 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 1 0.0017
290 STREPTOCOCCAL SEPSIS 2 0.0017
291 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
292 DYSPLASIA 2 0.0017
293 GASTROINTESTINAL TOXICITY 8 0.0017
294 FAT NECROSIS 1 0.0016
295 RETROPERITONEAL HAEMORRHAGE 4 0.0016
296 STAPHYLOCOCCAL SEPSIS 8 0.0016
297 BLOOD BILIRUBIN DECREASED 1 0.0016
298 PNEUMOCYSTIS JIROVECII PNEUMONIA 16 0.0016
299 NEUTROPENIA 216 0.0016
300 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
301 DRY GANGRENE 1 0.0016
302 NOCARDIOSIS 4 0.0016
303 ENDOCRINE DISORDER 2 0.0016
304 ENTEROCOLITIS 9 0.0016
305 TRAUMATIC LUNG INJURY 3 0.0016
306 ABDOMINAL WALL ABSCESS 1 0.0015
307 THROMBOTIC MICROANGIOPATHY 15 0.0015
308 ASPERGILLOSIS 2 0.0015
309 NON-HODGKIN'S LYMPHOMA 2 0.0015
310 OBLITERATIVE BRONCHIOLITIS 2 0.0015
311 ASPERGILLUS INFECTION 10 0.0015
312 HYPOGAMMAGLOBULINAEMIA 10 0.0015
313 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
314 DEVICE RELATED SEPSIS 3 0.0015
315 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
316 STENOTROPHOMONAS INFECTION 2 0.0015
317 AORTITIS 1 0.0015
318 FOETAL HYPOKINESIA 1 0.0014
319 RENAL TUBULAR DISORDER 4 0.0014
320 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
321 LYMPHOPENIA 20 0.0014
322 ABSCESS LIMB 6 0.0014
323 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
324 MENINGITIS BACTERIAL 2 0.0014
325 FOETAL EXPOSURE TIMING UNSPECIFIED 1 0.0014
326 AMNIOTIC CAVITY INFECTION 1 0.0014
327 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
328 GRAFT LOSS 1 0.0014
329 ESCHERICHIA SEPSIS 4 0.0014
330 CLONIC CONVULSION 1 0.0014
331 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
332 PNEUMONIA PNEUMOCOCCAL 2 0.0013
333 SKIN NECROSIS 7 0.0013
334 BASOPHIL COUNT INCREASED 1 0.0013
335 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
336 SEPTIC SHOCK 57 0.0013
337 PNEUMONIA PSEUDOMONAL 2 0.0013
338 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
339 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
340 THROMBOCYTOPENIA 143 0.0013
341 DISSEMINATED INTRAVASCULAR COAGULATION 18 0.0013
342 VARICELLA 3 0.0013
343 SEPSIS 140 0.0013
344 ENTERITIS 8 0.0012
345 PNEUMONIA LEGIONELLA 2 0.0012
346 LUNG INFECTION 19 0.0012
347 DYSCHROMATOPSIA 1 0.0012
348 ENTERITIS INFECTIOUS 2 0.0012
349 LUNG NEOPLASM 5 0.0012
350 HEPATOSPLENOMEGALY 3 0.0012
351 PSEUDOMONAS INFECTION 10 0.0012
352 PUPIL FIXED 2 0.0012
353 KIDNEY FIBROSIS 2 0.0012
354 SPLENIC INFARCTION 2 0.0011
355 EXFOLIATIVE RASH 3 0.0011
356 ABDOMINAL SEPSIS 1 0.0011
357 THROMBOTIC THROMBOCYTOPENIC PURPURA 4 0.0011
358 LOW BIRTH WEIGHT BABY 9 0.0011
359 WHITE BLOOD CELL DISORDER 3 0.0011
360 ESCHERICHIA INFECTION 9 0.0011
361 PNEUMONIA KLEBSIELLA 2 0.0011
362 BODY TEMPERATURE ABNORMAL 2 0.0011
363 PUPILLARY REFLEX IMPAIRED 2 0.0011
364 SERUM SICKNESS 3 0.0011
365 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
366 NEPHROPATHY TOXIC 12 0.0011
367 ADENOCARCINOMA OF COLON 2 0.0011
368 BUNDLE BRANCH BLOCK 1 0.0011
369 PROTEIN TOTAL DECREASED 4 0.0011
370 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
371 HYPOPROTEINAEMIA 2 0.0011
372 ANURIA 9 0.0010
373 MULTI-ORGAN FAILURE 18 0.0010
374 PANCYTOPENIA 58 0.0010
375 COLON NEOPLASM 1 0.0010
376 INTERSTITIAL LUNG DISEASE 50 0.0010
377 GASTROINTESTINAL NECROSIS 3 0.0010
378 BONE MARROW DEPRESSION 1 0.0010
379 ABDOMINAL WALL HAEMATOMA 2 0.0010
380 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29 0.0010
381 DEVICE RELATED THROMBOSIS 1 0.0010
382 ORGANISING PNEUMONIA 5 0.0010
383 KLEBSIELLA INFECTION 5 0.0010
384 AUTONOMIC NEUROPATHY 1 0.0010
385 FOETAL GROWTH RESTRICTION 6 0.0010
386 ENDOCARDITIS 5 0.0010
387 RESPIRATORY FAILURE 71 0.0010
388 BREAST NEOPLASM 1 0.0010
389 NEUTROPENIC COLITIS 2 0.0010
390 BONE MARROW OEDEMA 1 0.0010
391 LUNG ABSCESS 2 0.0010
392 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
393 HEPATITIS B REACTIVATION 3 0.0009
394 HYPERPHOSPHATAEMIA 2 0.0009
395 GINGIVITIS 5 0.0009
396 HEPATIC LESION 4 0.0009
397 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
398 CARDIAC AMYLOIDOSIS 1 0.0009
399 CLOSTRIDIUM TEST POSITIVE 2 0.0009
400 COMPLEX PARTIAL SEIZURES 1 0.0009
401 FAECES PALE 2 0.0009
402 BACTERIAL TEST POSITIVE 2 0.0009
403 PULMONARY HAEMORRHAGE 7 0.0009
404 ADENOCARCINOMA 2 0.0009
405 CANDIDA INFECTION 15 0.0009
406 CLOSTRIDIAL INFECTION 3 0.0009
407 NEOPLASM RECURRENCE 3 0.0009
408 SKIN TOXICITY 5 0.0009
409 NEUTROPHIL COUNT DECREASED 36 0.0009
410 BLOOD FIBRINOGEN DECREASED 1 0.0009
411 CORTISOL DECREASED 1 0.0009
412 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
413 CYTOMEGALOVIRUS COLITIS 2 0.0009
414 LARGE INTESTINE PERFORATION 6 0.0009
415 EPIDIDYMITIS 1 0.0009
416 MULTIPLE MYELOMA 4 0.0009
417 BRONCHIOLITIS 3 0.0009
418 PAPULE 6 0.0009
419 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
420 CLOSTRIDIUM COLITIS 1 0.0008
421 GENERALISED OEDEMA 10 0.0008
422 PYELONEPHRITIS 7 0.0008
423 BACTERIAL INFECTION 15 0.0008
424 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
425 PLATELET DISORDER 2 0.0008
426 LUNG INFILTRATION 7 0.0008
427 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 4 0.0008
428 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
429 CEREBRAL ISCHAEMIA 4 0.0008
430 HAEMOGLOBIN ABNORMAL 5 0.0008
431 PRODUCT USE IN UNAPPROVED INDICATION 191 0.0008
432 CANDIDIASIS 3 0.0007
433 ABDOMINAL MASS 2 0.0007
434 ORGAN FAILURE 3 0.0007
435 BLOOD BILIRUBIN INCREASED 20 0.0007
436 EFFUSION 1 0.0007
437 SUBDURAL HAEMORRHAGE 2 0.0007
438 HYPERURICAEMIA 3 0.0007
439 ABSCESS ORAL 1 0.0007
440 NEOPLASM PROGRESSION 25 0.0007
441 HYPOMAGNESAEMIA 10 0.0007
442 LUNG CONSOLIDATION 2 0.0007
443 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
444 NEUTROPHIL COUNT ABNORMAL 2 0.0007
445 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
446 PULMONARY TOXICITY 5 0.0007
447 PNEUMATOSIS INTESTINALIS 2 0.0007
448 LEUKOPENIA 35 0.0007
449 PNEUMONITIS 19 0.0007
450 PARAPLEGIA 2 0.0007
451 DYSPNOEA AT REST 2 0.0007
452 HAEMOTHORAX 2 0.0007
453 SPLENOMEGALY 8 0.0007
454 ASCITES 20 0.0007
455 GENITAL PAIN 1 0.0007
456 DISEASE PROGRESSION 80 0.0007
457 ODYNOPHAGIA 4 0.0007
458 BLOOD CULTURE POSITIVE 2 0.0007
459 BONE MARROW DISORDER 2 0.0007
460 CRANIOCEREBRAL INJURY 2 0.0007
461 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
462 IMMUNE THROMBOCYTOPENIA 3 0.0007
463 CYTOPENIA 8 0.0007
464 CHEST X-RAY ABNORMAL 2 0.0007
465 COAGULATION TIME PROLONGED 1 0.0006
466 AGRANULOCYTOSIS 12 0.0006
467 MULTIPLE-DRUG RESISTANCE 2 0.0006
468 HYPOALBUMINAEMIA 5 0.0006
469 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
470 OESOPHAGITIS 7 0.0006
471 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
472 INFECTION 92 0.0006
473 FUNGAEMIA 1 0.0006
474 RESPIRATORY DISORDER 19 0.0006
475 ORTHOPNOEA 2 0.0006
476 PNEUMONIA VIRAL 2 0.0006
477 TRANSPLANT REJECTION 5 0.0006
478 VENTRICULAR HYPOKINESIA 2 0.0006
479 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
480 ACUTE LEUKAEMIA 1 0.0006
481 FLUID OVERLOAD 9 0.0006
482 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
483 HYPOVENTILATION 2 0.0006
484 LYMPHOCYTE COUNT INCREASED 2 0.0006
485 HAEMORRHAGE INTRACRANIAL 9 0.0006
486 BREAST MASS 4 0.0006
487 ENTEROBACTER INFECTION 1 0.0006
488 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 1 0.0006
489 FOOD AVERSION 1 0.0006
490 B-CELL LYMPHOMA 2 0.0006
491 DISEASE RECURRENCE 28 0.0006
492 BLADDER NEOPLASM 1 0.0006
493 POLYNEUROPATHY 7 0.0006
494 BLOOD AMYLASE INCREASED 1 0.0006
495 HEPATOTOXICITY 13 0.0006
496 STAPHYLOCOCCAL INFECTION 19 0.0006
497 EXTREMITY NECROSIS 1 0.0006
498 URINE OUTPUT DECREASED 5 0.0006
499 NEUROTOXICITY 10 0.0006
500 FIBRIN D DIMER INCREASED 2 0.0006
501 CEREBRAL VENOUS THROMBOSIS 1 0.0006
502 CAROTID ARTERY OCCLUSION 2 0.0005
503 PNEUMONIA BACTERIAL 5 0.0005
504 STOMATITIS 33 0.0005
505 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
506 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
507 HYPOPHOSPHATAEMIA 4 0.0005
508 INTESTINAL PERFORATION 6 0.0005
509 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
510 STATUS EPILEPTICUS 6 0.0005
511 CHOLECYSTITIS ACUTE 3 0.0005
512 BILE DUCT OBSTRUCTION 1 0.0005
513 PLATELET COUNT DECREASED 56 0.0005
514 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
515 ALANINE AMINOTRANSFERASE INCREASED 32 0.0005
516 PERICARDIAL EFFUSION 12 0.0005
517 OPTIC ISCHAEMIC NEUROPATHY 2 0.0005
518 HYPOVOLAEMIA 3 0.0005
519 HYPERCHLORHYDRIA 3 0.0005
520 DRUG RESISTANCE 13 0.0005
521 OESOPHAGEAL CANDIDIASIS 2 0.0005
522 FUNGAL SKIN INFECTION 2 0.0005
523 TRANSAMINASES INCREASED 11 0.0005
524 HOMICIDAL IDEATION 2 0.0005
525 DIVERTICULAR PERFORATION 1 0.0005
526 ATRIAL THROMBOSIS 1 0.0005
527 OLIGURIA 3 0.0005
528 GASTROINTESTINAL PERFORATION 2 0.0005
529 BODY TEMPERATURE FLUCTUATION 1 0.0005
530 PLEURAL EFFUSION 29 0.0005
531 HALLUCINATIONS, MIXED 2 0.0005
532 SKIN LESION 13 0.0005
533 HYPERPYREXIA 2 0.0005
534 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
535 HEPATIC FAILURE 14 0.0005
536 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
537 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
538 HEPATIC FUNCTION ABNORMAL 17 0.0005
539 DEVICE RELATED INFECTION 7 0.0005
540 LYMPHOMA 7 0.0005
541 ANAEMIA 86 0.0005
542 CARDIAC FAILURE ACUTE 3 0.0004
543 ILEUS PARALYTIC 2 0.0004
544 ENCEPHALOPATHY 11 0.0004
545 COLITIS ISCHAEMIC 3 0.0004
546 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
547 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
548 TACHYPNOEA 6 0.0004
549 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
550 ABSCESS 7 0.0004
551 CHRONIC MYELOID LEUKAEMIA 2 0.0004
552 ESCHERICHIA BACTERAEMIA 1 0.0004
553 SQUAMOUS CELL CARCINOMA 4 0.0004
554 HYPOCALCAEMIA 8 0.0004
555 METASTASIS 3 0.0004
556 FUNGAL INFECTION 14 0.0004
557 ACUTE RESPIRATORY FAILURE 8 0.0004
558 GUILLAIN-BARRE SYNDROME 2 0.0004
559 HYPOKALAEMIA 19 0.0004
560 NO THERAPEUTIC RESPONSE 5 0.0004
561 CARDIOMYOPATHY 6 0.0004
562 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
563 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
564 PULMONARY MASS 6 0.0004
565 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
566 HYPERNATRAEMIA 2 0.0004
567 THERAPY NON-RESPONDER 18 0.0004
568 WHITE BLOOD CELL COUNT DECREASED 43 0.0004
569 COLITIS 15 0.0004
570 BRAIN ABSCESS 1 0.0004
571 HYPOTHERMIA 4 0.0004
572 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
573 EXCORIATION 1 0.0004
574 APPENDICITIS PERFORATED 1 0.0004
575 CANCER PAIN 1 0.0004
576 CEREBRAL HAEMORRHAGE 14 0.0004
577 HAEMOLYSIS 3 0.0004
578 BLOOD CHLORIDE DECREASED 1 0.0004
579 EJECTION FRACTION DECREASED 6 0.0004
580 THERAPY PARTIAL RESPONDER 6 0.0004
581 PYREXIA 132 0.0004
582 SERUM FERRITIN INCREASED 2 0.0004
583 ALCOHOL ABUSE 1 0.0004
584 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
585 HYPOXIA 13 0.0004
586 GINGIVAL BLEEDING 5 0.0004
587 DRUG LEVEL INCREASED 6 0.0004
588 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
589 EMBOLISM 3 0.0004
590 ANGIOPATHY 2 0.0004
591 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
592 SCAB 4 0.0004
593 NEUROLOGICAL SYMPTOM 2 0.0003
594 CARDIOGENIC SHOCK 5 0.0003
595 FIBULA FRACTURE 1 0.0003
596 LUNG DISORDER 17 0.0003
597 ACUTE KIDNEY INJURY 53 0.0003
598 PRODUCT USE ISSUE 65 0.0003
599 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
600 HYPERTRIGLYCERIDAEMIA 2 0.0003
601 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
602 PURPURA 3 0.0003
603 BRAIN HERNIATION 1 0.0003
604 ATYPICAL PNEUMONIA 1 0.0003
605 HEPATITIS B 2 0.0003
606 PATHOGEN RESISTANCE 3 0.0003
607 RESPIRATORY DISTRESS 9 0.0003
608 DUODENITIS 1 0.0003
609 BRAIN DEATH 1 0.0003
610 ILEUS 4 0.0003
611 BRAIN OEDEMA 4 0.0003
612 BREAST CANCER RECURRENT 1 0.0003
613 RENAL FAILURE 42 0.0003
614 PNEUMOTHORAX 5 0.0003
615 RASH MACULO-PAPULAR 7 0.0003
616 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
617 CUSHINGOID 1 0.0003
618 LYMPHADENOPATHY 11 0.0003
619 HEPATOMEGALY 3 0.0003
620 SKIN MASS 2 0.0003
621 PREMATURE BABY 9 0.0003
622 MALIGNANT MELANOMA 4 0.0003
623 FULL BLOOD COUNT DECREASED 6 0.0003
624 PERICARDITIS 5 0.0003
625 JAUNDICE 8 0.0003
626 BRONCHIECTASIS 2 0.0003
627 HERPES ZOSTER 17 0.0003
628 CIRCULATORY COLLAPSE 5 0.0003
629 ACUTE HEPATIC FAILURE 4 0.0003
630 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
631 ECCHYMOSIS 2 0.0003
632 HYPERBILIRUBINAEMIA 3 0.0003
633 NEURALGIA 7 0.0003
634 RHABDOMYOLYSIS 12 0.0003
635 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
636 PETECHIAE 3 0.0003
637 MOUTH ULCERATION 6 0.0003
638 PNEUMONIA 92 0.0003
639 HYPONATRAEMIA 16 0.0003
640 SUDDEN DEATH 3 0.0003
641 DIALYSIS 4 0.0003
642 DRUG EFFECT INCOMPLETE 10 0.0003
643 BLOOD PHOSPHORUS DECREASED 1 0.0003
644 NEUROPATHY PERIPHERAL 26 0.0003
645 MOUTH HAEMORRHAGE 2 0.0003
646 AMYLASE INCREASED 1 0.0003
647 TACHYCARDIA 24 0.0003
648 VENTRICULAR FIBRILLATION 3 0.0003
649 CARDIAC DYSFUNCTION 1 0.0003
650 HYDRONEPHROSIS 2 0.0003
651 RENAL IMPAIRMENT 22 0.0003
652 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
653 MYOCARDITIS 3 0.0003
654 ACIDOSIS 2 0.0003
655 LIPASE INCREASED 2 0.0003
656 RENAL FAILURE CHRONIC 2 0.0003
657 ELECTROLYTE IMBALANCE 3 0.0003
658 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
659 CARDIOPULMONARY FAILURE 1 0.0003
660 NERVOUS SYSTEM DISORDER 8 0.0003
661 PLASMA CELL MYELOMA 10 0.0003
662 ATAXIA 3 0.0003
663 BLOOD ALBUMIN DECREASED 2 0.0003
664 CEREBRAL ATROPHY 1 0.0003
665 RED BLOOD CELL COUNT DECREASED 7 0.0002
666 DEMYELINATION 1 0.0002
667 SMALL INTESTINAL OBSTRUCTION 3 0.0002
668 HYPERCALCAEMIA 3 0.0002
669 COAGULOPATHY 4 0.0002
670 CONGESTIVE CARDIOMYOPATHY 1 0.0002
671 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
672 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
673 SKIN ULCER 6 0.0002
674 BLOOD MAGNESIUM DECREASED 2 0.0002
675 TOXICITY TO VARIOUS AGENTS 39 0.0002
676 BLOOD CREATININE INCREASED 15 0.0002
677 ORAL CANDIDIASIS 3 0.0002
678 LYMPHOCYTE COUNT DECREASED 4 0.0002
679 HAEMOLYTIC ANAEMIA 2 0.0002
680 MYOSITIS 2 0.0002
681 DEVELOPMENTAL DELAY 2 0.0002
682 LEUKOCYTOSIS 4 0.0002
683 DRUG TOXICITY 3 0.0002
684 DISEASE COMPLICATION 1 0.0002
685 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
686 UROSEPSIS 2 0.0002
687 DEEP VEIN THROMBOSIS 14 0.0002
688 HEPATIC STEATOSIS 4 0.0002
689 ERYTHEMA MULTIFORME 2 0.0002
690 LEUKAEMIA 2 0.0002
691 HEPATOCELLULAR INJURY 3 0.0002
692 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
693 CARDIAC TAMPONADE 1 0.0002
694 SUBDURAL HAEMATOMA 3 0.0002
695 HEPATIC CANCER 5 0.0002
696 ATELECTASIS 2 0.0002
697 GASTROENTERITIS 3 0.0002
698 RENAL TUBULAR NECROSIS 2 0.0002
699 ACUTE MYOCARDIAL INFARCTION 6 0.0002
700 IMMUNODEFICIENCY 3 0.0002
701 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
702 ERYSIPELAS 1 0.0002
703 CELLULITIS 10 0.0002
704 CARDIOVASCULAR DISORDER 5 0.0002
705 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
706 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
707 CACHEXIA 1 0.0002
708 DECREASED APPETITE 45 0.0002
709 PERITONITIS 4 0.0002
710 FAILURE TO THRIVE 1 0.0002
711 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
712 DIARRHOEA 123 0.0002
713 CATATONIA 1 0.0002
714 HALLUCINATION, AUDITORY 3 0.0002
715 ANAL FISTULA 1 0.0002
716 CARDIAC FAILURE 15 0.0002
717 ANAL ABSCESS 1 0.0002
718 BRUXISM 1 0.0002
719 BEHAVIOUR DISORDER 1 0.0002
720 OFF LABEL USE 160 0.0002
721 STEVENS-JOHNSON SYNDROME 4 0.0002
722 ORAL PAIN 4 0.0002
723 HEMIPARESIS 3 0.0002
724 GRANULOCYTOPENIA 1 0.0002
725 NEOPLASM 2 0.0002
726 LETHARGY 10 0.0002
727 CAESAREAN SECTION 2 0.0002
728 VASCULITIS 2 0.0002
729 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
730 HYPERKALAEMIA 6 0.0002
731 DRUG ERUPTION 3 0.0002
732 CHOLECYSTITIS 2 0.0002
733 MYELOSUPPRESSION 6 0.0002
734 OEDEMA 9 0.0002
735 HYPOTENSION 33 0.0002
736 DERMATITIS ACNEIFORM 1 0.0002
737 CEREBRAL INFARCTION 4 0.0002
738 EPILEPSY 5 0.0002
739 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
740 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
741 PHARYNGITIS 2 0.0002
742 DRUG-INDUCED LIVER INJURY 5 0.0002
743 INTESTINAL OBSTRUCTION 6 0.0002
744 CARDIAC ARREST 13 0.0002
745 CHOLESTASIS 3 0.0002
746 ATRIAL FIBRILLATION 15 0.0002
747 VOMITING 72 0.0002
748 GASTRITIS 4 0.0002
749 DISORIENTATION 6 0.0002
750 CORONAVIRUS INFECTION 1 0.0002
751 TYPE 2 DIABETES MELLITUS 5 0.0001
752 TASTE DISORDER 3 0.0001
753 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
754 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
755 PULMONARY EMBOLISM 14 0.0001
756 HAEMOGLOBIN DECREASED 15 0.0001
757 GASTROINTESTINAL DISORDER 13 0.0001
758 ENCEPHALITIS 1 0.0001
759 HAEMORRHAGE 15 0.0001
760 HAEMOPTYSIS 4 0.0001
761 DERMATITIS 3 0.0001
762 MASS 2 0.0001
763 HALLUCINATION, VISUAL 3 0.0001
764 THROMBOSIS 11 0.0001
765 MELAENA 3 0.0001
766 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
767 LIVER DISORDER 6 0.0001
768 PULMONARY OEDEMA 6 0.0001
769 RASH PAPULAR 3 0.0001
770 PANCREATITIS ACUTE 3 0.0001
771 THERAPEUTIC RESPONSE DECREASED 8 0.0001
772 HAEMODYNAMIC INSTABILITY 1 0.0001
773 ABDOMINAL PAIN 30 0.0001
774 APHTHOUS ULCER 1 0.0001
775 BASAL CELL CARCINOMA 2 0.0001
776 MENINGIOMA 2 0.0001
777 CHILLS 15 0.0001
778 CYANOSIS 2 0.0001
779 GINGIVAL PAIN 1 0.0001
780 ATRIAL FLUTTER 1 0.0001
781 RHINORRHOEA 8 0.0001
782 DECUBITUS ULCER 1 0.0001
783 LIVER INJURY 3 0.0001
784 SKIN DISORDER 4 0.0001
785 DYSPHONIA 7 0.0001
786 FLUID RETENTION 6 0.0001
787 CARDIAC MURMUR 1 0.0001
788 RESPIRATORY TRACT INFECTION 3 0.0001
789 MUSCULOSKELETAL PAIN 6 0.0001
790 GROIN PAIN 1 0.0001
791 GASTROENTERITIS VIRAL 2 0.0001
792 PELVIC PAIN 2 0.0001
793 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
794 END STAGE RENAL DISEASE 2 0.0001
795 MENTAL STATUS CHANGES 3 0.0001
796 CONJUNCTIVITIS 2 0.0001
797 APPENDICITIS 1 0.0001
798 DIARRHOEA HAEMORRHAGIC 1 0.0001
799 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
800 OEDEMA PERIPHERAL 13 0.0001
801 ARRHYTHMIA 5 0.0001
802 CONVULSION 6 0.0001
803 HYPOGLYCAEMIA 5 0.0001
804 HEPATIC ENZYME INCREASED 7 0.0001
805 LABORATORY TEST ABNORMAL 3 0.0001
806 BODY TEMPERATURE DECREASED 1 0.0001
807 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
808 HAEMATOCRIT DECREASED 2 0.0001
809 DRY EYE 5 0.0001
810 CYTOKINE RELEASE SYNDROME 2 0.0001
811 APHASIA 3 0.0001
812 EYELID PTOSIS 1 0.0001
813 DRUG LEVEL DECREASED 1 0.0001
814 DRUG ADMINISTRATION ERROR 3 0.0001
815 DEHYDRATION 13 0.0001
816 INFLAMMATION 5 0.0001
817 CYSTITIS 3 0.0001
818 RETCHING 2 0.0001
819 EPISTAXIS 7 0.0001
820 NAUSEA 74 0.0001
821 LIVER FUNCTION TEST INCREASED 2 0.0001
822 BREAST CANCER METASTATIC 1 0.0001
823 RASH PRURITIC 5 0.0001
824 MENTAL DISORDER 4 0.0001
825 CONSTIPATION 20 0.0001
826 HYPERSENSITIVITY 17 0.0001
827 HYPERTENSION 19 0.0001
828 THROAT IRRITATION 4 0.0001
829 FISTULA 1 0.0001
830 BLOOD CALCIUM DECREASED 1 0.0001
831 HAEMATURIA 3 0.0001
832 CARDIAC FAILURE CONGESTIVE 7 0.0001
833 DEATH 75 0.0001
834 SHOCK 2 0.0001
835 GASTRIC HAEMORRHAGE 1 0.0001
836 EYELID OEDEMA 1 0.0001
837 SWELLING 8 0.0001
838 BONE PAIN 5 0.0001
839 COVID-19 PNEUMONIA 1 0.0001
840 SKIN EXFOLIATION 7 0.0001
841 HYPERGLYCAEMIA 3 0.0001
842 CARDIOMEGALY 1 0.0001
843 CONFUSIONAL STATE 13 0.0001
844 DYSPNOEA EXERTIONAL 3 0.0001
845 SEIZURE 9 0.0001
846 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
847 ANOREXIA 1 0.0001
848 UNRESPONSIVE TO STIMULI 2 0.0001
849 RASH GENERALISED 2 0.0001
850 DIPLOPIA 2 0.0001
851 DEAFNESS 2 0.0001
852 ALOPECIA 15 0.0001
853 SEDATION 2 0.0001
854 ABNORMAL BEHAVIOUR 3 0.0001
855 RASH 33 0.0001
856 PANCREATITIS 4 0.0001
857 DRUG INEFFECTIVE 99 0.0001
858 NEOPLASM MALIGNANT 5 0.0001
859 PALLOR 2 0.0001
860 RESPIRATORY ARREST 2 0.0001
861 TREATMENT FAILURE 6 0.0001
862 CARDIO-RESPIRATORY ARREST 3 0.0001
863 COUGH 20 0.0001
864 BLINDNESS UNILATERAL 1 0.0001
865 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
866 BRONCHOSPASM 1 0.0001
867 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
868 DRUG INTERACTION 11 0.0001
869 VAGINAL HAEMORRHAGE 3 0.0001
870 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
871 LIVER FUNCTION TEST ABNORMAL 2 0.0001
872 PSYCHOTIC DISORDER 2 0.0001
873 OESOPHAGEAL CARCINOMA 2 0.0001
874 RENAL INJURY 2 0.0001
875 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
876 CHRONIC KIDNEY DISEASE 5 0.0001
877 CONDITION AGGRAVATED 20 0.0001
878 WEIGHT DECREASED 18 0.0001
879 RENAL DISORDER 3 0.0001
880 EXPOSURE DURING PREGNANCY 4 0.0001
881 CARDIAC DISORDER 6 0.0001
882 RASH ERYTHEMATOUS 3 0.0001
883 HYPOTHYROIDISM 2 0.0001
884 METABOLIC ACIDOSIS 2 0.0001
885 DYSPNOEA 35 0.0001
886 IMPAIRED HEALING 2 0.0001
887 OSTEONECROSIS 2 0.0001
888 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
889 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
890 VISUAL ACUITY REDUCED 2 0.0001
891 HYPOAESTHESIA 9 0.0001
892 VIRAL INFECTION 2 0.0001
893 SYNCOPE 6 0.0001
894 URINARY TRACT INFECTION 10 0.0001
895 DELIRIUM 2 0.0001
896 RASH MACULAR 2 0.0001
897 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
898 ASTHENIA 21 0.0001
899 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
900 C-REACTIVE PROTEIN INCREASED 2 0.0001
901 HAEMATOCHEZIA 3 0.0001
902 ANAPHYLACTIC REACTION 3 0.0001
903 INFLUENZA 6 0.0001
904 WEIGHT INCREASED 12 0.0001
905 BLISTER 3 0.0001
906 OXYGEN SATURATION DECREASED 3 0.0001
907 FATIGUE 41 0.0001
908 DIABETES MELLITUS 4 0.0001
909 DRUG INTOLERANCE 5 0.0001
910 MYOCARDIAL INFARCTION 9 0.0001
911 PALPITATIONS 6 0.0001
912 WHEEZING 3 0.0001
913 BLOOD PRESSURE ABNORMAL 1 0.0001
914 IRRITABILITY 3 0.0000
915 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
916 BLINDNESS 2 0.0000
917 OSTEOPOROSIS 2 0.0000
918 AMNESIA 3 0.0000
919 INTENTIONAL PRODUCT MISUSE 4 0.0000
920 BLOOD PRESSURE DECREASED 3 0.0000
921 CHROMATURIA 1 0.0000
922 VISION BLURRED 6 0.0000
923 ADVERSE EVENT 4 0.0000
924 CHEST PAIN 8 0.0000
925 COGNITIVE DISORDER 2 0.0000
926 OCULAR HYPERAEMIA 2 0.0000
927 COMA 2 0.0000
928 ABDOMINAL DISCOMFORT 7 0.0000
929 CONTUSION 4 0.0000
930 DYSPEPSIA 4 0.0000
931 UNEVALUABLE EVENT 3 0.0000
932 ABDOMINAL PAIN LOWER 1 0.0000
933 HAEMATEMESIS 1 0.0000
934 SINUSITIS 4 0.0000
935 ANAPHYLACTIC SHOCK 1 0.0000
936 ECZEMA 2 0.0000
937 DEPRESSED MOOD 2 0.0000
938 BRADYCARDIA 2 0.0000
939 DIVERTICULITIS 1 0.0000
940 MYALGIA 6 0.0000
941 MUSCULAR WEAKNESS 4 0.0000
942 BACK PAIN 8 0.0000
943 DYSSTASIA 1 0.0000
944 MUSCULOSKELETAL STIFFNESS 3 0.0000
945 PAIN IN EXTREMITY 10 0.0000
946 ADVERSE DRUG REACTION 3 0.0000
947 BLOOD POTASSIUM DECREASED 1 0.0000
948 PARAESTHESIA 5 0.0000
949 SWELLING FACE 2 0.0000
950 EYE DISORDER 1 0.0000
951 HEART RATE INCREASED 3 0.0000
952 ABDOMINAL PAIN UPPER 6 0.0000
953 ABDOMINAL DISTENSION 3 0.0000
954 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
955 DYSGEUSIA 2 0.0000
956 HALLUCINATION 2 0.0000
957 ARTHRITIS 2 0.0000
958 MALAISE 11 0.0000
959 SOMNOLENCE 5 0.0000
960 DRY MOUTH 2 0.0000
961 DYSKINESIA 1 0.0000
962 INFLUENZA LIKE ILLNESS 2 0.0000
963 LOSS OF CONSCIOUSNESS 3 0.0000
964 HYPERHIDROSIS 3 0.0000
965 HEADACHE 14 0.0000
966 NO ADVERSE EVENT 4 0.0000
967 ARTHRALGIA 9 0.0000
968 OROPHARYNGEAL PAIN 2 0.0000
969 HOSPITALISATION 3 0.0000
970 PRURITUS 7 0.0000
971 TREMOR 3 0.0000
972 FLATULENCE 1 0.0000
973 GAIT DISTURBANCE 3 0.0000
974 PAIN 9 0.0000
975 OVERDOSE 3 0.0000
976 AGITATION 1 0.0000
977 BRONCHITIS 1 0.0000
978 DEPRESSION 3 0.0000
979 BLOOD PRESSURE INCREASED 2 0.0000
980 DIZZINESS 6 0.0000
981 CEREBROVASCULAR ACCIDENT 2 0.0000
982 INSOMNIA 3 0.0000
983 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
984 BREAST CANCER 1 0.0000
985 ERYTHEMA 2 0.0000
986 INCORRECT DOSE ADMINISTERED 2 0.0000
987 COVID-19 1 0.0000
988 BLOOD GLUCOSE INCREASED 1 0.0000